UBS Shares Struggle Despite Record Profits and Integration Milestones
12.03.2026 - 04:35:56 | boerse-global.deUBS has reported exceptionally strong full-year financial results and is making rapid progress in absorbing Credit Suisse. Yet, despite announcing a multi-billion dollar profit and a significant dividend hike, its stock has been on a persistent downward trajectory since January. This divergence raises questions about why the market is not rewarding these operational achievements.
Strategic Moves Amidst Share Price Weakness
The bank is concurrently strengthening its governance. At the upcoming Annual General Meeting in April, prominent figures such as former Bank for International Settlements head Agustín Carstens are slated to join the Board of Directors, a move designed to bolster regulatory expertise. So far, however, these strategic decisions have failed to impress equity investors. Since the start of the year, UBS shares have shed approximately 16% of their value, closing at 33.72 euros on Wednesday. This price action has pushed the stock slightly below the closely watched 200-day moving average, which currently stands at 34.25 euros.
A Fundamentally Robust Performance
The recently published and audited annual report for 2025 confirms the positive preliminary figures released in February. Operationally, the bank appears very sturdy, posting a net profit of nearly $7.8 billion and overseeing client assets that now exceed the $7 trillion mark. Shareholders are set to benefit from this performance through a proposed dividend increase of 22% to $1.10 per share. Furthermore, the bank has firmly outlined plans for additional dividend raises in 2026 and share buybacks totaling $3 billion.
The Costly Reality of Merging a Giant
Beneath the headline numbers, potential reasons for investor caution become apparent. While UBS expects to have migrated almost all relevant client accounts to its own platforms by the end of March, the integration carries a heavy price. Globally, the number of severance payments rose to over 7,500 cases last year, up from approximately 5,700 in the prior year. These substantial restructuring costs, coupled with an integration process scheduled to continue through the end of 2026, tie up capital and continue to pose operational risks to the smooth running of daily business.
Should investors sell immediately? Or is it worth buying UBS?
The gap between the company's fundamental earnings power and its weak share price performance underscores the sustained wariness among market participants. An immediate and crucial test lies ahead: The final client migrations from Credit Suisse must be executed flawlessly by the end of this month. Success is critical to bolstering investor confidence in UBS's targeted medium-term return on equity goal of 15% by the end of 2026.
Ad
UBS Stock: New Analysis - 12 March
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis UBS Aktien ein!
Für. Immer. Kostenlos.

